Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

ALP10 Apolipoprotein A-I, human

ALP10
500 µg  
Purchase on Sigma-Aldrich

Panoramica

Replacement Information
Description
Catalogue NumberALP10
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionApolipoprotein A-I, human
OverviewHigh Density Lipoprotein (HDL) isolated by ultracentrifugation are delipidated. Apo A-I is purified by column chromatography in 6M urea (Schonfeld et al. 1977). Purity is determined by quantitative densitometric of SDS polyacrylamide gels (Laemlli 1970). Protein is determined by the Pierce BCA method (which was found to be comparable to the Lowry method) with BSA as the standard.

MOLECULAR WEIGHT:

28,000
Alternate Names
  • ApoAI
References
Product Information
PresentationLiquid in 10 mM NH4HCO3, pH 7.4. Non-sterile, no preservatives.
Quality LevelMQ100
Applications
Key Applications
  • Positive Control
Biological Information
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
Purity> 98%.
SourceNormal human plasma, fresh, non-frozen. Tested negative for HIV-1, HIV-2, HCV and HBc antibodies and HBsAg.
Entrez Gene Number
Entrez Gene SummaryThis gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis.
Gene Symbol
  • APOA1
  • ApoA-I
  • MGC117399
  • preproapolipoprotein
  • amyloidosis
  • Apo-AI
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P02647 # Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT).
SIZE: 267 amino acids; 30778 Da
SUBUNIT: Interacts with APOA1BP.
SUBCELLULAR LOCATION: Secreted.
TISSUE SPECIFICITY: Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine.
PTM: Palmitoylated.
DISEASE: SwissProt: P02647 # Defects in APOA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) [MIM:604091]; also known as familial hypoalphalipoproteinemia (FHA). Inheritance is autosomal dominant. & Defects in APOA1 are a cause of the low HDL levels observed in high density lipoprotein deficiency type 1 (HDLD1) [MIM:205400]; also known as analphalipoproteinemia or Tangier disease (TGD). HDLD1 is a recessive disorder characterized by the absence of plasma HDL, accumulation of cholesteryl esters, premature coronary artery disease, hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness. In HDLD1 patients, ApoA-I fails to associate with HDL probably because of the faulty conversion of pro-ApoA-I molecules into mature chains, either due to a defect in the converting enzyme activity or a specific structural defect in Tangier ApoA-I. & Defects in APOA1 are a cause of systemic non-neuropathic amyloidosis [MIM:105200]; also known as amyloidosis VIII or Ostertag-type amyloidosis. It is an autosomal dominant disorder characterized by generalized amyloid deposition.
SIMILARITY: SwissProt: P02647 ## Belongs to the apolipoprotein A1/A4/E family.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain lyophilized material at < -20°C for up to six months. Maintain reconstituted Apo A-I at +4°C up to 4 weeks. Freezing solutions of apolipoproteins in the absence of denaturants may favor increased self-association or aggregation.
Packaging Information
Material Size500 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
ALP10 04053252371134

Documentation

Apolipoprotein A-I, human MSDS

Titolo

Scheda di sicurezza (MSDS) 

Apolipoprotein A-I, human Certificati d'Analisi

TitoloNumero di lotto
PURIFIED HUMAN APOLIPOPROTEIN A-I 3088413
PURIFIED HUMAN APOLIPOPROTEIN A-I 3088395
PURIFIED HUMAN APOLIPOPROTEIN A-I 3156052
PURIFIED HUMAN APOLIPOPROTEIN A-I 3050824
PURIFIED HUMAN APOLIPOPROTEIN A-I 2883019
PURIFIED HUMAN APOLIPOPROTEIN A-I 2943226
PURIFIED HUMAN APOLIPOPROTEIN A-I 3058440
PURIFIED HUMAN APOLIPOPROTEIN A-I 3111176
PURIFIED HUMAN APOLIPOPROTEIN A-I 3117695
PURIFIED HUMAN APOLIPOPROTEIN A-I 2474871

Riferimenti bibliografici

Panoramica dei riferimenti bibliograficiCodice d'identificazione nel Pub Med
Effect of pressure and ionic strength on the self-association of Apo-A-I from the human high density lipoprotein complex.
Formisano, S, et al.
J. Biol. Chem., 253: 354-9 (1978)  1977

Mostra il sommario
201629 201629
Apolipoprotein A-II content of human plasma high density lipoproteins measured by radioimmunoassay.
Schonfeld, G, et al.
J. Lipid Res., 18: 645-55 (1977)  1976

Mostra il sommario
198505 198505

Prodotti e applicazioni correlate

Alternative Packsize

Numero di catalogo Descrizione
ALP10-KC Apolipoprotein A-I, human (1mg) KC

Linee di prodotti

Categorie

Life Science Research > Proteins and Enzymes > Other Proteins